TY - JOUR
T1 - Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy
AU - Kawamura, Yoshiki
AU - Nakayama, Ai
AU - Kato, Taichi
AU - Miura, Hiroki
AU - Ishihara, Naoko
AU - Ihira, Masaru
AU - Takahashi, Yukitoshi
AU - Matsuda, Kazumi
AU - Yoshikawa, Tetsushi
N1 - Publisher Copyright:
© 2015 The Author.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Human herpesvirus 6B (HHV-6B) is the causative agent for exanthem subitum. HHV-6B was associated with mesial temporal sclerosis (MTS), leading to mesial temporal lobe epilepsy (MTLE). In this study, we sought to elucidate the pathogenic role of HHV-6B in patients with MTLE. Methods. Seventy-five intractable MTLE patients, including 52 MTS patients and 23 non-MTS patients, were enrolled in this study. Resected hippocampus, amygdala, and mixed samples of amygdala and uncus samples were examined by real-time polymerase chain reaction (PCR) and reverse-transcriptase PCR to detect viral DNA and messenger RNA (mRNA), respectively. Host gene expressions, including neural markers, were measured using the TaqMan Gene Expression Assay. Results. Detection of HHV-6 DNA was higher in MTS patients than non-MTS patients (median/interquartile range: 19.1/0-89.2 vs 0.0/0.0-0.0 copies/μg DNA; P = .004). HHV-6B viral DNA was determined in 12/27 HHV-6 DNA-positive samples, and no HHV-6B mRNA were detected in all samples. In MTS patients, expression of monocyte chemotactic protein-1 (P = .029) and glial fibrillary acidic protein (P = .043) were significantly higher in the amygdala samples with HHV-6 DNA than those without viral DNA. Conclusions. This study suggests that HHV-6B may play an important role in the pathogenesis of MTS via modification of host gene expression.
AB - Human herpesvirus 6B (HHV-6B) is the causative agent for exanthem subitum. HHV-6B was associated with mesial temporal sclerosis (MTS), leading to mesial temporal lobe epilepsy (MTLE). In this study, we sought to elucidate the pathogenic role of HHV-6B in patients with MTLE. Methods. Seventy-five intractable MTLE patients, including 52 MTS patients and 23 non-MTS patients, were enrolled in this study. Resected hippocampus, amygdala, and mixed samples of amygdala and uncus samples were examined by real-time polymerase chain reaction (PCR) and reverse-transcriptase PCR to detect viral DNA and messenger RNA (mRNA), respectively. Host gene expressions, including neural markers, were measured using the TaqMan Gene Expression Assay. Results. Detection of HHV-6 DNA was higher in MTS patients than non-MTS patients (median/interquartile range: 19.1/0-89.2 vs 0.0/0.0-0.0 copies/μg DNA; P = .004). HHV-6B viral DNA was determined in 12/27 HHV-6 DNA-positive samples, and no HHV-6B mRNA were detected in all samples. In MTS patients, expression of monocyte chemotactic protein-1 (P = .029) and glial fibrillary acidic protein (P = .043) were significantly higher in the amygdala samples with HHV-6 DNA than those without viral DNA. Conclusions. This study suggests that HHV-6B may play an important role in the pathogenesis of MTS via modification of host gene expression.
UR - http://www.scopus.com/inward/record.url?scp=84943375686&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84943375686&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiv160
DO - 10.1093/infdis/jiv160
M3 - Article
C2 - 25840441
AN - SCOPUS:84943375686
SN - 0022-1899
VL - 212
SP - 1014
EP - 1021
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 7
ER -